Skip to main content

Vertex Pharmaceuticals Inc 10-Q for FY2023 Q3

Vertex Pharmaceuticals Inc (VRTX)

10-Q 2023-11-07 For: 2023-09-30
View Original
Added on April 02, 2026

About this 10-Q

Vertex Pharmaceuticals Inc filed this 10-Q on November 7, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).

Headline figures

Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$2.48B
up 6.4% from $2.33B a year earlier
Net income
$1.04B
up 11.3% from net income of $930.5M a year earlier
Diluted EPS
$3.97
up 10.6% from $3.59 a year earlier